Evaluate the complexity of the technical issues related to managing and utilizing genomic data as discussed in chapter 24. Without discrimination as the framework, preventive medicine and wellness models may desire genetic testing in adults to identify genetic diseases before they cause symptoms. Outline the considerations for the shifts in health care delivery caused by personalized medicine including the management of personalized data.

Evaluate the complexity of the technical issues related to managing and utilizing genomic data as discussed in chapter 24. Without discrimination as the framework, preventive medicine and wellness models may desire genetic testing in adults to identify genetic diseases before they cause symptoms. Outline the considerations for the shifts in health care delivery caused by personalized medicine including the management of personalized data.

Comprehensive Medical Assisting: Administrative and Clinical Competencies (MindTap Course List)

6th Edition

ISBN:9781305964792

Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa

Publisher:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa

Chapter22: The Patient History And Documentation

Section: Chapter Questions

Problem 8CR

See similar textbooks

Similar questions

A nurse researcher studies the effects of genomics on cur- rent nursing practice. Which statements identify genetic principles that will challenge nurses to integrate genomics in their research, education, and practice? Select all that apply. a. Genetic tests plus family history tools have the potential to identify people at risk for diseases. b. Pharmacogenetic tests can determine if a patient is likely to have a strong therapeutic response to a drug or suffer adverse reactions from the medication.c. Evidence-based review panels are in place to evaluate the possible risks and benefits related to genetic testing. d. Valid and reliable national data are available to establish baseline measures and track progress toward targets. e. Genetic variation can either accelerate or slow the metabo- lism of many drugs. f. It is beyond the role of the nurse to answer questions and discuss the impact of genetic findings on health and illness.
Describe the purpose of ICD-10-CM coding in the health care revenue cycle.Explain the purpose of CPT as it relates to the health care revenue cycle.Describe the effect of HCPCS coding on the health care revenue cycle.
Define the following notions and elaborate on their ethical implications: Stem Cell Tourism. Therapeutic Misconception
Identify the regulatory and ethical issues related to gene therapy as related to nursing and health care professionals.
Which of the following actions is NOT performed during the risk characterization phase of a risk assessment? O A. summarize risk information for public and policy holders B. communicate estimates of adverse health effects with non-cancer hazard quotients O c. identify the hazard and exposed populations O D. evaluate uncertainty O E. communicate estimates of cancer risks
Answer the following questions related to bias in screening studies. A- Explain in your own word, how might lead-time bias give a misleading picture of the benefits of treatment? B- Explain in your own word, length-time bias and at least one potential effects that it can have on the validity of a study
Identify ethical and legal issues in end-of-lifecare, including advance directives, physicianorders, and euthanasia.
Objective: Identify risk management strategies to address medical malpractice within a healthcare setting. Reviewing this case study, https://www.acpjournals.org/doi/10.7326/0003-4819-139-4-200308190-00009 From a risk management perspective, what could have been done to prevent malpractice litigation, what can be done in the future? Explain your rationale.
Do you think direct-to-consumer tests that provide information about the risk of developing medical conditions (such as breast cancer or Alzheimer disease) should be made available to the public? List some arguments for and against providing this service.
Discuss the evolving role of professional nurses as related to gene therapy
Which of the following is a barrier to recruitment in a clinical trial? A. Investment in community education and outreach. B. Education about clinical trials early in a patient's diagnosis. C. Presentation of options for the patient. D. Strick protocols and narrow eligibility guidelines.
Outline an experimental approach using a dietary intervention for designing a novel supplement against a NCD of your choice. Describe your research hypothesis and what you are going to measure. (i) Phrase a specific health claim that can be used for this novel product.